# Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

> **NCT04604613** · — · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 518 (actual)

## Conditions studied

- FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
- FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma

## Interventions

- **PROCEDURE:** Bilateral Salpingectomy with Oophorectomy
- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Hysterectomy
- **OTHER:** Laboratory Biomarker Analysis
- **PROCEDURE:** Lymph Node Mapping
- **PROCEDURE:** Sentinel Lymph Node Biopsy

## Key facts

- **NCT ID:** NCT04604613
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2012-11-08
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 518 (ACTUAL)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04604613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04604613, "Prediction of Recurrence Among Low Risk Endometrial Cancer Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04604613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*